Company intelligence / Profile preview

Kahun

Ownership: Private
Development stage: Commercial

Overview

Kahun has developed an explainable generative AI platform that structures vast amounts of medical knowledge into a knowledge graph, enabling robust clinical decision support tools. Its main products include a clinical assessment chatbot and a pharma-focused AI agent that provide real-time, evidence-based insights to healthcare professionals. The company’s technology is used in partnerships such as with the New England Journal of Medicine (NEJM Healer) to enhance medical education and clinical reasoning training[4][5][7]. There are no drug development or traditional clinical trial results as it is not a therapeutics company.

Industry: Digital Health Medical Devices

Partnerships

New England Journal of Medicine (NEJM Healer application)MediOrbis

Beyond the preview

Go deeper on Kahun.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kahun.

Explore the full profile